Growth Metrics

Merck (MRK) Dividends Paid - Common Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Paid (Common) Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 15.01%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 4.75%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 5.50%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 2.68%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 6.18%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 3.59%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 0.33%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 1.99%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.68%
Dec 31, 2025 3.43%
Sep 30, 2025 3.99%
Jun 30, 2025 4.58%
Mar 31, 2025 5.13%
Dec 31, 2024 5.35%
Sep 30, 2024 5.28%
Jun 30, 2024 5.36%
Mar 31, 2024 5.23%
Dec 31, 2023 5.83%
Sep 30, 2023 6.18%
Jun 30, 2023 6.50%
Mar 31, 2023 6.19%
Dec 31, 2022 6.51%
Sep 30, 2022 5.94%
Jun 30, 2022 5.80%
Mar 31, 2022 6.08%
Dec 31, 2021 6.55%
Sep 30, 2021 6.73%
Jun 30, 2021 6.09%
Mar 31, 2021 6.06%
Dec 31, 2020 9.75%
Sep 30, 2020 10.83%
Jun 30, 2020 7.43%
Mar 31, 2020 8.61%
Dec 31, 2019 10.02%
Sep 30, 2019 8.48%
Jun 30, 2019 11.98%
Mar 31, 2019 9.93%
Dec 31, 2018 -0.47%
Sep 30, 2018 0.16%
Jun 30, 2018 0.31%
Mar 31, 2018 0.39%
Dec 31, 2017 0.94%
Sep 30, 2017 0.71%
Jun 30, 2017 0.54%
Mar 31, 2017 1.17%
Dec 31, 2016 0.63%
Sep 30, 2016 0.16%
Jun 30, 2016 -0.15%
Mar 31, 2016 -0.08%
Dec 31, 2015 0.32%
Sep 30, 2015 -0.78%
Jun 30, 2015 -2.76%
Mar 31, 2015 -0.78%
Dec 31, 2014 -0.08%
Sep 30, 2014 1.83%
Jun 30, 2014 0.53%
Mar 31, 2014 -1.23%
Dec 31, 2013 133.91%
Sep 30, 2013 -1.41%
Jun 30, 2013 4.06%
Mar 31, 2013 2.11%
Dec 31, 2012 -9.10%
Sep 30, 2012 8.68%
Jun 30, 2012 8.84%
Mar 31, 2012 8.85%
Dec 31, 2011 0.99%
Sep 30, 2011 -0.51%
Jun 30, 2011 -1.09%
Mar 31, 2011 -1.18%
Dec 31, 2010 -527.75%
Sep 30, 2010 46.91%
Jun 30, 2010 48.00%
Mar 31, 2010 47.98%